大豆对2型糖尿病合并亚临床性腺功能减退男性的影响:一项随机对照研究
这项在英国的随机双盲平行研究纳入200例总睾酮≤12 nmol/L的2型糖尿病男性,比较每日15 g大豆蛋白联合66 mg异黄酮(SPI)与15 g大豆蛋白(SP)干预3个月。结果显示两组总睾酮和绝对游离睾酮均无变化,SPI组血糖和心血管风险指标改善更明显,但促甲状腺激素升高、游离甲状腺素降低。
要点
- SPI与SP均未改变总睾酮或绝对游离睾酮水平。
- SPI组糖化血红蛋白和胰岛素抵抗指数显著降低。
- SPI组促甲状腺激素升高、游离甲状腺素降低(P<0.01)。
核心结论
- 与单用大豆蛋白相比,加用异黄酮的大豆蛋白干预3个月可改善血糖和心血管风险指标,但睾酮水平无变化,且促甲状腺激素升高、游离甲状腺素降低。
研究设计与样本
- 随机双盲平行研究,在英国二级医疗中心纳入200例总睾酮≤12 nmol/L的2型糖尿病男性。
- 干预为每日15 g大豆蛋白联合66 mg异黄酮(SPI)或15 g大豆蛋白(SP)作为零食棒,持续3个月。
主要发现
- SPI或SP均未改变总睾酮或绝对游离睾酮水平。
- SPI补充后促甲状腺激素升高、游离甲状腺素降低(P<0.01)。
- SPI组糖化血红蛋白降低-4.19(7.29)mmol/mol(P<0.01),胰岛素抵抗指数亦降低。
- 与SP组相比,SPI组甘油三酯、C反应蛋白和舒张压降低(P<0.05),10年冠心病风险改善6%。
- SPI和SP均改善内皮功能(P<0.01),SPI组反应性充血指数增加更明显(P<0.05)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Isoflavones found in soy products have a chemical structure similar to estrogen, leading to concerns of an adverse estrogenic effect in men, particularly in those with type 2 diabetes mellitus (T2DM) who have low testosterone levels due to hypogonadism. OBJECTIVE: The primary outcome was change in total testosterone levels. The secondary outcomes were the changes in glycemia and cardiovascular risk markers. DESIGN: This was a randomized double-blind parallel study. SETTING: This study occurred in a secondary care setting in United Kingdom. PARTICIPANTS: Two hundred men with T2DM and a total testosterone level ≤12 nmol/L were included. INTERVENTION: Fifteen grams of soy protein with 66 mg of isoflavones (SPI) or 15 g soy protein alone without isoflavones (SP) daily as snack bars for 3 months were administered. RESULTS: There was no change in either total testosterone or in absolute free testosterone levels with either SPI or SP. There was an increase in thyrotropin (TSH) and reduction in free thyroxine (fT4; P < 0.01) after SPI supplementation. Glycemic control improved with a significant reduction in hemoglobin A1c (-4.19 [7.29] mmol/mol, P < 0.01) and homeostasis model of assessment - insulin resistance after SPI. Cardiovascular risk improved with a reduction in triglycerides, C-reactive protein, and diastolic blood pressure (DBP; P < 0.05) with SPI vs SP supplementation. There was a 6% improvement in 10-year coronary heart disease risk after 3 months of SPI supplementation. Endothelial function improved with both SPI and SP supplementation (P < 0.01), with an increased reactive hyperemia index that was greater for the SPI group (P < 0.05). CONCLUSIONS: Testosterone levels were unchanged and there was a substantial improvement in glycaemia and cardiovascular risk markers with SPI compared with SP alone over 3 months. There was also a substantial increase in TSH and a reduction in fT4.
引用
- Sathyapalan T, Rigby AS, Bhasin S, et al. Effect of Soy in Men With Type 2 Diabetes Mellitus and Subclinical Hypogonadism: A Randomized Controlled Study. J Clin Endocrinol Metab. 2017. PMID: 27797674. doi:10.1210/jc.2016-2875
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。